MEASUREMENTS: Main outcome measure was the time from baseline to nursing home admission. Baseline evaluation of motor symptoms (Unified Parkinson's Disease Rating Scale, UPDRS), cognition (clinical dementia interview, Gottfries, Bråne & Steen dementia scale, and Mini-Mental State Examination), depression (clinical interview and the Montgomery & Åsberg Depression Rating Scale), and psychotic symptoms (UPDRS Thought Disorder item) were performed.

RESULTS: Forty-seven patients (26.4%) were admitted to a nursing home during the 4-year study period. Institutionalized patients were older, had more advanced Parkinson's disease with more severe motor symptoms and impairment of activities of daily living, were cognitively more impaired, were more often living alone, and had more hallucinations than those who continued to live at home. Duration of disease, levodopa dose, and gender distribution did not differ between the two groups. A Cox proportional hazards linear regression analysis showed that old age, functional impairment, dementia, and hallucinations were independent predictors of nursing home admission.

CONCLUSIONS: Both motor and neuropsychiatric symptoms contributed to institutionalization, but the presence of hallucinations was the strongest predictor. This finding indicates it is possible that effective treatment of hallucinations may reduce the need for institutionalization in patients with Parkinson's disease. J Am Geriatr Soc 48:938–942, 2000.

REFERENCES

1 Larsen JP and the Norwegian Study Group of Parkinson's Disease in the Elderly. Parkinson's disease as a community health problem: Study in Norwegian nursing homes. BMJ 1991; 303: 741–743.
10.1136/bmj.303.6805.741
PubMedGoogle Scholar
2 Mitchell SL, Kiely DK, Kiel DP, Lipsitz LA. The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson's disease. J Am Geriatr Soc 1996; 44: 394–399.
10.1111/j.1532-5415.1996.tb06408.x
CASPubMedWeb of Science®Google Scholar
3 Branch LG, Jette AM. A prospective study of long-term care institutionalization among the aged. Am J Public Health 1982; 72: 1373–1379.
10.2105/AJPH.72.12.1373
CASPubMedWeb of Science®Google Scholar
4 Greene VL, Ondrich JI. Risk factors for nursing home admissions and exits: A discrete-time hazard function approach. J Gerontol 1990; 45: S250–258.
10.1093/geronj/45.6.S250
CASPubMedWeb of Science®Google Scholar
5 Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993; 43: 2227–2229.
10.1212/WNL.43.11.2227
CASPubMedWeb of Science®Google Scholar
6 Tandberg E, Larsen JP, Nessler EG et al. The epidemiology of Parkinson's disease in the county of Rogaland, Norway. Mov Disord 1995; 10: 541–549.
10.1002/mds.870100503
CASPubMedWeb of Science®Google Scholar
7 Fahn S, Elton RL. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: S Fahn, CD Marsden, DB Calne, A Lieberman, eds. Recent Development in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information, 1987, pp 153–63.
Google Scholar
8 Hoehn MH, Yahr MD. Parkinsonism. Onset, progression, and mortality. Neurology 1967; 17: 427–442.
10.1212/WNL.17.5.427
CASPubMedWeb of Science®Google Scholar
9 Larsen JP, Dupont E, Tandberg E. The clinical diagnosis of Parkinson's disease: Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 1994; 84: 242–251.
Google Scholar
10 Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed Rev. Washington DC: American Psychiatric Association, 1987.
Google Scholar
11 Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”. A practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.
10.1016/0022-3956(75)90026-6
CASPubMedWeb of Science®Google Scholar
12 Gottfries CG, Bråne G, Gullberg B, Steen G. A new rating scale for dementia syndromes. Arch Gerontol Geriatr 1982; 1: 311–330.
10.1016/0167-4943(82)90031-0
PubMedGoogle Scholar
13 Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–389.
10.1192/bjp.134.4.382
CASPubMedWeb of Science®Google Scholar
14 Aarsland D, Tandberg E, Larsen JP, Cummings JL. Frequency of dementia in Parkinson's disease. Arch Neurol 1996; 53: 538–542.
10.1001/archneur.1996.00550060082020
CASPubMedWeb of Science®Google Scholar
15 Tandberg E, Larsen JP, Aarsland D et al. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 1996; 53: 175–179.
10.1001/archneur.1996.00550020087019
CASPubMedWeb of Science®Google Scholar
16 Aarsland D, Larsen JP, Cummings JL et al. Prevalence and clinical correlates of psychosis in Parkinson's disease. Arch Neurol 1999; 56: 595–601.
10.1001/archneur.56.5.595
CASPubMedWeb of Science®Google Scholar
17 Colerick EJ, George LK. Predictors of institutionalization among caregivers of patients with Alzheimer's disease. J Am Geriatr Soc 1986; 34: 493–498.
10.1111/j.1532-5415.1986.tb04239.x
CASPubMedWeb of Science®Google Scholar
18 O'Reilly F, Finnan F, Allwright S et al. The effects of caring for a spouse with Parkinson's disease on social, psychological and physical well-being. Br J Gen Pract 1996; 46: 507–512.
CASPubMedWeb of Science®Google Scholar
19 Aarsland D, Larsen JP, Karlsen K et al. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999; 14: 866–874.
10.1002/(SICI)1099-1166(199910)14:10<866::AID-GPS38>3.0.CO;2-Z
CASPubMedWeb of Science®Google Scholar
20 Haupt M, Romero B, Kurz A. Delusions and hallucinations in Alzheimer's disease: Results from a two-year longitudinal study. Int J Geriatr Psychiatry 1996; 11: 965–972.
10.1002/(SICI)1099-1166(199611)11:11<965::AID-GPS418>3.0.CO;2-M
Google Scholar
21 Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: Drug-induced psychiatric states. In: WJ Weiner, AE Lang, eds. Behavioral Neurology of Movement Disorders. Adv Neurol 1995; 65: 115–138.
Google Scholar
22 The Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med 1999; 340: 757–763.
10.1056/NEJM199903113401003
PubMedWeb of Science®Google Scholar
23 Aarsland D, Larsen JP, Lim NG. Olanzapine for psychosis in patients with Parkinson's disease with and without dementia. J Neuropsychiatr Clin Neurosci 1999; 11: 393–394.
10.1176/jnp.11.3.392
Google Scholar

Citing Literature

Volume48, Issue8

August 2000

Pages 938-942

Predictors of Nursing Home Placement in Parkinson's Disease: A Population-Based, Prospective Study

Abstract

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Predictors of Nursing Home Placement in Parkinson's Disease: A Population-Based, Prospective Study

Abstract

REFERENCES

Citing Literature

References

Related

Information